Katarina Ivana Tudor1,2, Jai H Seth3, Martina D Liechti3,4,5, Juliana Ochulor3, Gwen Gonzales3, Collette Haslam3, Zoe Fox6, Mahreen Pakzad3, Jalesh N Panicker3. 1. Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Queen Square, London, UK. katarina.ivana.tudor@kbc-zagreb.hr. 2. Department of Neurology, University Hospital Center Zagreb, Kispaticeva 12, 10000, Zagreb, Croatia. katarina.ivana.tudor@kbc-zagreb.hr. 3. Department of Uro-Neurology, The National Hospital for Neurology and Neurosurgery, UCL Institute of Neurology, Queen Square, London, UK. 4. Department of Brain Repair and Rehabilitation, UCL Institute of Neurology, Queen Square, London, UK. 5. Spinal Cord Injury Center, University of Zurich, Balgrist University Hospital, Zurich, Switzerland. 6. Biostatistics Group, University College London Hospitals and University College London Research Support Centre, University College London, London, UK.
Abstract
PURPOSE: Percutaneous tibial nerve stimulation is a minimally invasive neuromodulation technique for treating overactive bladder symptoms. The aim of this study was to assess safety, efficacy and impact on quality of life of percutaneous tibial nerve stimulation in neurological patients reporting overactive bladder symptoms. METHODS: In this retrospective evaluation over 18 months at a tertiary healthcare centre, patients finding first-line treatments for overactive bladder ineffective or intolerable underwent a standard 12-week course of percutaneous tibial nerve stimulation (Urgent PC, Uroplasty). Symptoms were evaluated using standardised International Consultation on Incontinence Questionnaires and bladder diaries. RESULTS: Of 74 patients (52 women, 22 men, mean age 56 years), 49 (66.2%) patients had neurological disorder [19 (25.7%) multiple sclerosis and 30 (40.5%) other neurological conditions] and 25 (33.8%) idiopathic overactive bladder. Overall for the entire cohort significant improvements were recorded after 12 weeks in the following domains: 24-h frequency on bladder diary - 1.67 (- 3.0, 0.33) (p = 0.002), number of incontinent episodes on bladder diary - 0.0 (- 1, 0) (p = 0.01), incontinence severity on bladder diary 0 (- 0.33, 0) (p = 0.007), OAB symptoms - 3 (- 11.5, 5) (p = 0.01), and quality of life - 16 (- 57, 6.5) (p = 0.004). There were no significant differences in outcomes between patients with idiopathic and neurogenic overactive bladder. CONCLUSIONS: Percutaneous tibial nerve stimulation appears to be a possible promising alternative for patients with neurological disorder reporting overactive bladder symptoms who find first-line treatments either ineffective or intolerable. However, a properly designed study is required to address safety and efficacy.
PURPOSE: Percutaneous tibial nerve stimulation is a minimally invasive neuromodulation technique for treating overactive bladder symptoms. The aim of this study was to assess safety, efficacy and impact on quality of life of percutaneous tibial nerve stimulation in neurological patients reporting overactive bladder symptoms. METHODS: In this retrospective evaluation over 18 months at a tertiary healthcare centre, patients finding first-line treatments for overactive bladder ineffective or intolerable underwent a standard 12-week course of percutaneous tibial nerve stimulation (Urgent PC, Uroplasty). Symptoms were evaluated using standardised International Consultation on Incontinence Questionnaires and bladder diaries. RESULTS: Of 74 patients (52 women, 22 men, mean age 56 years), 49 (66.2%) patients had neurological disorder [19 (25.7%) multiple sclerosis and 30 (40.5%) other neurological conditions] and 25 (33.8%) idiopathic overactive bladder. Overall for the entire cohort significant improvements were recorded after 12 weeks in the following domains: 24-h frequency on bladder diary - 1.67 (- 3.0, 0.33) (p = 0.002), number of incontinent episodes on bladder diary - 0.0 (- 1, 0) (p = 0.01), incontinence severity on bladder diary 0 (- 0.33, 0) (p = 0.007), OAB symptoms - 3 (- 11.5, 5) (p = 0.01), and quality of life - 16 (- 57, 6.5) (p = 0.004). There were no significant differences in outcomes between patients with idiopathic and neurogenic overactive bladder. CONCLUSIONS: Percutaneous tibial nerve stimulation appears to be a possible promising alternative for patients with neurological disorder reporting overactive bladder symptoms who find first-line treatments either ineffective or intolerable. However, a properly designed study is required to address safety and efficacy.
Entities:
Keywords:
Lower urinary tract symptoms; Multiple sclerosis; Overactive bladder; Percutaneous electric nerve stimulation; Quality of life
Authors: Kenneth M Peters; Donna J Carrico; Scott A MacDiarmid; Leslie S Wooldridge; Ansar U Khan; Craig E McCoy; Nicholas Franco; Jason B Bennett Journal: Neurourol Urodyn Date: 2012-06-05 Impact factor: 2.696
Authors: Floor van der Pal; Michael R van Balken; John P F A Heesakkers; Frans M J Debruyne; Bart L H Bemelmans Journal: BJU Int Date: 2006-03 Impact factor: 5.588
Authors: Scott A MacDiarmid; Kenneth M Peters; S Abbas Shobeiri; Leslie S Wooldridge; Eric S Rovner; Fah Che Leong; Steven W Siegel; Susan B Tate; Brian A Feagins Journal: J Urol Date: 2010-01 Impact factor: 7.450